UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites ▼ | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
A0A8J0SJZ3 | Pannexin |
|
1 | 0 |
|
A0A6I8QW04 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0JPB5 | Membrane protein FAM174 |
|
1 | 0 |
|
A0A6I8PVK0 | Hyaluronidase |
|
1 | 0 |
|
Q28ES4 | Solute carrier family 22 member 15-like |
|
1 | 0 |
|
A0A8J0SCK5 | Tartrate-resistant acid phosphatase type 5 |
|
1 | 0 |
|
A0A8J1IRF3 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A803KFL5 | Paraoxonase |
|
1 | 0 |
|
F6WKR0 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A6I8SF09 | Proto-oncogene tyrosine-protein kinase receptor Ret |
|
1 | 0 |
|
A0A8J0QFI1 | Peptidyl-glycine alpha-amidating monooxygenase isoform 1 precursor |
|
1 | 0 |
|
A4IGQ6 | Hyaluronidase |
|
1 | 0 |
|
A0A8J1JBS3 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
Q6WRY0 | Ammonium transporter Rh type C |
|
1 | 0 |
|
A0A803JFY5 | P2X purinoceptor |
|
1 | 0 |
|
A0A8J1J9B3 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A6I8SE58 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
F6XBA4 | Tartrate-resistant acid phosphatase type 5 |
|
1 | 0 |
|
A4IGU2 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A8J1IMU9 | Voltage-dependent N-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A6I8SK99 | P2X purinoceptor |
|
1 | 0 |
|
F6VMH9 | Potassium channel subfamily K member |
|
1 | 0 |
|
A0A6I8Q9Q8 | Phosphoinositide phospholipase C |
|
1 | 0 |
|
Q05B21 | Vesicular glutamate transporter 1 |
|
1 | 0 |
|
B0BM11 | Hyaluronidase |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025